amoxicillin potassium clavulanate tablet

Ashtavinayaka Export is a leading global supplier and exporter of Amoxyheal CV 1000, a powerful antibiotic formulation containing Amoxicillin 875 mg, widely used for treating bacterial infections. Manufactured under strict quality standards, this medication is in high demand across international markets. 🌍 Global Export Markets We supply Amoxyheal CV 1000 Amoxycillin 875 mg Tablets to major countries and cities including: USA (New York, Los Angeles) UK (London, Manchester) Singapore France (Paris) Germany (Berlin, Munich) Thailand (Bangkok) Poland (Warsaw) Italy (Rome, Milan) Hong Kong Philippines (Manila) Canada (Toronto, Vancouver) Switzerland (Zurich, Geneva) 💊 Product Overview Product Name: Amoxyheal CV 1000 Composition: Amoxycillin 875 mg + Clavulanic Acid Category: Broad-Spectrum Antibiotic Form: Tablets Usage: Treatment of respiratory, urinary tract, skin, and bacterial infections Packaging: Export-quality packaging as per international standards 🚀 Why Choose Ashtavinayaka Export? WHO-GMP certified pharmaceutical sourcing Competitive pricing for bulk orders Fast global shipping & secure logistics Trusted exporter from India Customized packaging for international markets Strong presence in regulated and semi-regulated markets Amoxyheal CV 1000 exporter, Amoxycillin 875 mg supplier India, Amoxicillin clavulanate export, bulk antibiotic tablets exporter, pharma export India, Amoxycillin 875 mg wholesale, antibiotic tablets supplier USA UK, Amoxicillin global distributor, pharmaceutical exporter Singapore France Germany, buy Amoxycillin online international, antibiotic supplier Thailand Poland Italy, Hong Kong pharma distributors, Canada Switzerland medicine supplier, UK London pharmaceutical import 📦 Bulk Supply & Export Inquiry Looking for a reliable Amoxycillin 875 mg exporter from India? Ashtavinayaka Export ensures consistent quality, timely delivery, and competitive pricing for all global buyers. 👉 Contact us today for bulk orders, pricing, and export documentation.